Fischer Medical Ventures Ltd — Important, 18-08-2025: Company Update

Fischer Medical Ventures' board has approved the financial results for the quarter and half-year, reporting a consolidated profit of Rs 5.01 Cr on consolidated revenue of Rs 23.44 Cr. The board decided to hold its 32nd Annual General Meeting virtually. Share transfer books will be closed for a period in late September, and M/s Nuren Lodaya & Associates has been appointed as Scrutinizer for e-voting. The board also proposed their appointment as Secretarial Auditors for five years and noted the resignation of Dr. Jacob Thomas, an Independent Director, due to personal reasons.